BioFinlandin jäsen

Zora Biosciences is a diagnostics discovery company. We identify markers of disease and develop them into robust high-throughput, value-added clinical methods. The IP we find in our discovery work will generate clinical diagnostic tests for improved patient care and will drive reduction of health care costs. Our flagship product is CERT, Cardiovascular Event Risk Test, widely available for clinical use in USA and Finland.